Ectopic ATP5B, which is located in a unique type of lipid raft caveolar structure, can be upregulated by cholesterol loading. As the structural component of caveolae, Cav-1 is a molecular hub that is involved in transmembrane signaling. In a previous study, the ATP5B-specific binding peptide B04 was shown to inhibit the migration and invasion of prostate cancer cells, and the expression of ATP5B on the plasma membrane of MDA-MB-231 cells was confirmed. The present study investigated the effect of ectopic ATP5B on the migration and invasion of MDA-MB-231 cells and examined the involvement of Cav-1. Cholesterol loading increased the level of ectopic ATP5B and promoted cell migration and invasion. These effects were blocked by B04. Ectopic ATP5B was physically colocalized with Cav-1, as demonstrated by double immunofluorescence staining and coimmunoprecipitation. After Cav-1 knockdown, the migration and invasion abilities of MDA-MB-231 cells were significantly decreased, suggesting that Cav-1 influences the function of ectopic ATP5B. Furthermore, these effects were not reversed after treatment with cholesterol. We concluded that Cav-1 may participate in MDA-MB-231 cell migration and invasion induced by binding to ectopic ATP5B.
Hinweise
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Introduction
As the most common malignancy in women, breast cancer accounts for 18% of female cancer cases [1]. Each year, there are approximately 1.7 million newly diagnosed breast cancer cases worldwide and 500,000 patients die of breast cancer [2, 3]. Most breast cancers are invasive. Although distant metastasis in patients diagnosed with early breast cancer accounts for only 5–10% of all cases, the risk of metastasis remains quite high after primary surgical resection and adjuvant radiotherapy. Metastasis of breast cancer increases the cost of treatment and creates an economic burden for patients. Therefore, there is an urgent need to identify the metastasis-associated proteins in breast cancer.
Adenosine triphosphate synthase beta subunit (ATP5B) is the β subunit of F1F0-ATP synthase and contains the catalytic site for ATP synthesis as well as hydrolysis [4]. As a subunit of F1F0-ATP synthase, ATP5B was once thought to be strictly located at the inner side of the mitochondrial membrane. However, more recent studies have revealed its ectopic expression on the outer surface of the plasma membrane of highly metabolic cells, where it is called ectopic ATP5B [5]. Ectopic ATP5B was identified as the receptor for apolipoprotein A on hepatocytes, and it participates in the endocytosis of holo-HDL particles [6]. In adipocytes, the ectopic ATP5B level is significantly increased during adipogenesis [7, 8]. Additionally, ectopic ATP5B exhibits antiangiogenic and antitumorigenic effects [9‐13]. Antibodies against the β subunit of ATPase show angiostatin-like properties and are cytotoxic to tumor cells by regulating intracellular pH [14]. Many of the examined markers were of greater or lesser clinical significance [15‐18].
Anzeige
ATP5B is transferred to the plasma membrane in a punctate form, similar to the distribution pattern of caveolae. Caveolae are 50–100 nm wide, flask-shaped plasma membrane invaginations that constitute a subcompartment of the cell membrane [19]. Caveolae serve as microdomains in which signaling molecules and trafficking vesicles are concentrated [4]. Caveolin-1 (Cav-1), a resident protein of lipid rafts and caveolae and the major structural protein of caveolae, is essential for the formation of caveolae and is implicated in numerous signal transduction pathways [20]. Cav-1 is an essential role of invadopodia-mediated breast cancer cell invasion by regulating MMP [21]. Two isoforms of Cav-1 have been found as a consequence of alternative translation initiation sites. Cav-1α has 178 amino acids, and Cav-1β lacks the 32 N-terminal residues of Cav-1α [22]. However, the functional differences between the two isoforms are still unclear.
In our preliminary work, ectopic ATP5B was identified as a binding partner of metastasis-related short peptide B04 on PC-3 M cells and found to be associated with prostate cancer metastasis [23]. Furthermore, ectopic ATP5B has a tendency to be highly expressed on the plasma membrane of highly invasive cells, including MDA-MB-231 breast cancer cells. The present study intended to investigate the role of plasma membrane ATP5B in breast cancer migration and invasion and examine the involvement of Cav-1.
Materials and methods
Cell culture
The breast cancer cell line MDA-MB-231 (American Type Culture Collection, Manassas, VA, USA) was routinely cultured in H-DMEM supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were maintained at 37 °C in a humidified atmosphere containing 5% CO2.
Double immunofluorescence staining
Cells were fixed first with 2.5% glutaraldehyde at room temperature for 15 min and then with 4% paraformaldehyde for 15 min. After washing in PBS three times, cells were incubated with 5% BSA for 1 h and were then incubated with the primary anti-ATP5B antibody (diluted 1:100) and anti-Cav-1 antibody (diluted 1:200) at 4 °C overnight. After three washes with PBS, cells were incubated with secondary antibodies (anti-mouse IgG Alexa Fluor 488, 1:500; goat anti-rabbit IgM/Alexa Fluor 555, 1:200) for 1 h. Cells were then washed with PBS and stained with Hoechst 33,342 (diluted 1:1000) for 8 min. Images were acquired under an inverted phase contrast fluorescence microscope. The images were acquired using an Olympus FV-1000 confocal laser scanning microscope (Olympus, Tokyo, Japan).
Anzeige
Construction of Cav-1-shRNA plasmids and stable transfection of cells
All Cav-1-shRNAs were synthesized by GENECHEM (Shanghai, China). The Cav-1 shRNA1 target sequence was 5’- GAC CCA CTC TTT GAA GCT GTT-3’. The Cav-1 shRNA2 target sequence was 5’- CCA CCT TCA CTG TGA CGA AAT-3’. The scrambled shRNA target sequence was 5’- TTC TCC GAA CGT GTC ACGT-3’. Each pair of shRNAs was ligated into the GV418 plasmid. The shRNA fragments within the vector construct were sequenced using the primer H1-F (5’-GGA AAG AAT AGT AGA CAT AAT AGC-3’). The targeting and scramble vectors were transfected into MDA-MB-231 cells using Lipofectamine 2000 reagent (Invitrogen, USA). Briefly, MDA-MB-231 cells were subcultured in 24-well plates (5 × 104 cells/well) at 37 °C in a humidified atmosphere of 5% CO2 for 24 h. The diluted plasmids and liposomes were incubated in serum- and antibiotic-free Opti-MEM for 5 min and were then added to the cell culture plates. The transfected cells were cultured for 6 h and were then transferred to a fresh medium containing 10% FBS. Puromycin was used to select the positive clones.
Immuno precipitation
Plasma membrane proteins were extracted using a Minute™ Plasma Membrane Protein Isolation Kit (Invent Biotechnologies, USA) according to the manufacturer’s instructions. Plasma membrane proteins were precleared with Protein A/G Plus agarose beads, and aliquots of the supernatant were incubated first with the anti-ATP5B antibody or normal mouse IgG overnight at 4 °C and then with Protein A/G Plus agarose beads at 4 °C for 3 h. The beads were collected by centrifugation at 10,000 × g for 15 s at 4 °C and washed with PBS.
Western blotting
Western blotting was performed as described previously [24]. Briefly, cell lysates were analyzed by SDS-PAGE and transferred onto PVDF membranes. Membranes were blocked for 1 h at room temperature in buffer containing 10% skim milk powder and were then incubated overnight at 4 °C with different primary antibodies (anti-ATP5B, anti-Cav-1, anti-Na+-K+ ATPase α). After washing three times, membranes were incubated with secondary antibodies for 1 h at room temperature. The signals of the detected proteins were visualized with an ECL detection system (Amersham Biosciences, USA).
RT-PCR
Total RNA was extracted using TRIzol reagent (Takara, Dalian, China) according to the manufacturer’s instructions. mRNA levels were assessed with RT-PCR (Transgen, Beijing, China). Gene expression levels were normalized to that of an endogenous reference gene, β-actin. Experiments were performed in triplicate. The primer sequences for β-actin detection were as follows: forward, 5’- TCA TGA AGT GTG ACG TGG ACA TC -3’ and reverse, 5’- CAG GAG GAG CAA TGA TCT TGA TCT -3’. The primer sequences for Cav-1 detection were as follows: forward, 5’- CTA CAA GCC CAA CAA CAA GGC -3’ and reverse, 5’- AGG AAG CTC TTG ATG CAC GGT -3’.
Migration assay
Migration assays were performed in 24-well plates with 8-μm pore-sized chamber inserts (Costar, Corning, Inc.). Approximately 4 × 104 cells/well were resuspended in 200 μl of serum-free medium with or without cholesterol/B04 and were then seeded in the upper chambers. In addition, 700 μl of medium supplemented with 10% FBS was added to the lower chambers. The cells were incubated at 37 °C and 5% CO2 for 24 h, after which the cells on the upper surface of the filters were gently removed by wiping with a moist cotton swab. The cells on the lower surface of the membranes were fixed with paraformaldehyde solution for 10 min and stained with 0.1% crystal violet. The number of migration cells was counted under an inverted phase contrast microscope.
Invasion assay
Invasion assays were performed in 24-well plates by inserting with 8 μm pore size (Costar, Corning, Inc.). Cells were cultured in serum-free medium for 24 h before the invasion assay. The upper chamber inserts were coated with 60 μl of Matrigel (dilution 1:4, BD), and 1 × 105 cells were seeded in the upper chamber of each well. Chamber was incubated for 72 h at 37 °C in a 5% CO2 atmosphere and then matrigel on the upper surface of membrane were removed, and the cells on the lower surface of the membrane were washed and fixed in methanol for 5 min. The number of invaded cells was estimated by staining with 0.1% crystal violet.
Statistical analysis
All experiments were repeated at least three times and all data were expressed as the mean ± SEM. Differences between the means were analyzed using two-way analysis of variance (ANOVA). Statistical analysis of the data was performed using GraphPad Prism Software. The significance level was set at *p < 0.05, **p < 0.01, and ***p < 0.001.
Results
Ectopic ATP5B binds to Cav-1β on the cell membrane
Ectopic ATP5B is usually distributed in caveolae on the cell surface [4]. In addition, Cav-1 has been demonstrated to interact with ATP5B in endothelial cells. To verify the association of plasma membrane ATP5B with Cav-1 on MDA-MB-231 cells, we used double immunofluorescence staining (nonpermeabilized cells). As shown in Fig. 1a, ATP5B and Cav-1 were colocalized on the surface of MDA–MB-231 breast cancer cells. Then, we used antibodies against ATP5B to immunoprecipitate Cav-1 from plasma membrane proteins, and we detected Cav-1β, one isoform of Cav-1, in the immunoprecipitates (Fig. 1b.)
Fig. 1
The interaction of ectopic ATP5B and Cav-1. a Ectopic ATP5B and Cav-1 colocalization in MDA-MB-231 cells (200 ×). Hoechst 33,342-stained nuclei: blue; ATP5B: green; Cav-1: red; the merged image shows the colocalization of nuclei, ATP5B and Cav-1. ATP5B and Cav-1 colocalization: yellow. Scatter analysis showing the signals in the channels for Alexa Fluor 488 (ATP5B) and Alexa Fluor 555 (Cav-1). b ATP5B was immunoprecipitated from plasma membrane proteins using an anti-ATP5B antibody. The immunoprecipitates were separated by SDS-PAGE for detection of Cav-1 by western blotting
×
Anzeige
Cholesterol loading increases the levels of ectopic ATP5B and Cav-1
Cholesterol loading increases the translocation of ATP5B to the plasma membrane in ECs [25]. To validate the role of ectopic ATP5B in the migration and invasion of breast cancer cells, we treated MDA-MB-231 cells with cholesterol (20 μg/mL in ethanol) for different times. Then, the membrane proteins were extracted, and the ectopic expression of ATP5B and Cav-1 was evaluated by western blot analysis. Relative to those in control cells, the levels of ectopic ATP5B and Cav-1 were significantly increased in cells treated with cholesterol for 12 h (Fig. 2). Cholesterol loading promoted ectopic expression of ATP5B and Cav-1 on the plasma membrane of MDA-MB-231 cells, but this effect was not persistent.
Fig. 2
Cholesterol loading increases ectopic expression of plasma membrane ATP5B. a Plasma membrane proteins were extracted from MDA-MB-231 cells exposed to free cholesterol for 0 h, 12 h, and 24 h. The levels of ectopic ATP5B and Cav-1 were analyzed by western blotting. b, c The asterisks indicate significant differences between the control group and the 12 h-treated group from three independent experiments. **p < 0.01, ***p < 0.001. The values shown represent mean ± SEM, with n = 3
×
Ectopic ATP5B promotes the invasion and migration of MDA-MB-231 breast cancer cells
We then investigated the potential role of ectopic ATP5B in the migration and invasion of MDA-MB-231 cells. MDA-MB-231 cells were exposed to cholesterol to increase the ectopic expression of plasma membrane ATP5B and Cav-1. The cells were subjected to cell migration and invasion assays in Transwell chambers. B04 (an ATP5B-specific binding peptide) was used to exclude the effects of cholesterol and Cav-1 on cell migration and invasion. As shown in Fig. 3, compared to the control group, MDA-MB-231 cells treated with B04 had significantly lower migration and invasion capacities than untreated cells. In contrast, cholesterol loading increased the number of migrated and invaded cells. However, the numbers of migrated and invaded cells treated with B04 before exposure to cholesterol were not different from those in the group treated with B04 alone. These results suggest that cholesterol loading promotes cell migration and invasion by inducing ectopic expression of ATP5B.
Fig. 3
Effect of ectopic ATP5B on the migration and invasion of MDA-MB-231 cells. a Transwell migration (n = 3) and invasion (n = 3) assays showed that MDA-MB-231 cells exposed to B04 had decreased migration and invasion potential compared with untreated cells. In contrast, cells treated with cholesterol exhibited the opposite behavior. The migratory and invasive abilities of cells exposed to cholesterol after incubation with B04 (ATP5B-specific binding peptide) were not different from those of cells treated with B04 alone. b Statistical results from (A). Data are presented as the mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001, two-way ANOVA. Data are representative of three independent experiments
To further explore the function of Cav-1 in the MDA-MB-231 cell migration and invasion induced by ectopic ATP5B, we transfected MDA-MB-231 cells with a plasmid in which shRNA sequences targeting Cav-1 had been cloned. The plasmid expressed green fluorescent protein (GFP) to allow observation of the transfected cells by fluorescence microscopy. Cells were selected with puromycin (5 μg/mL) for approximately three weeks, and positive cell clones were identified by fluorescence microscopy (Fig. 4a). RT-PCR (Fig. 4b and c) and western blot (Fig. 4d and e) analyses revealed that the Cav-1 mRNA and protein levels of Cav-1 shRNA1-transfected cells were significantly lower than those of the scramble vector-transfected cells. However, Cav-1 expression showed no difference in Cav-1 shRNA2- and scramble vector-transfected cells. Cells transfected with the Cav-1 shRNA1 plasmid showed high knockdown efficiency of Cav-1 and were used in the following experiments; these cells are consistently referred to as Cav-1 shRNA cells.
Fig. 4
Screening and identification of cells with stable knockdown of Cav-1. a Transfected cells were selected with puromycin for three weeks (200 ×). b Detection of Cav-1 mRNA by RT-PCR. The gene expression level was normalized to that of an endogenous reference gene, β-actin. c The statistical results of RT-PCR. *p < 0.05, **p < 0.01. The value shown represent mean ± SEM, with n = 3. d Detection of the level of Cav-1 by western blotting. The protein expression level was normalized to that of an endogenous reference protein, β-actin. e The statistical results of the western blot analysis. *p < 0.05, **p < 0.01. The value shown represent mean ± SEM, with n = 3
×
Knocking down Cav-1 decreases plasma membrane Cav-1 expression and blocks the effects of cholesterol
Plasma membrane proteins of transfected cells were extracted and detected by western blotting. The level of Cav-1 was decreased in the Cav-1 shRNA group compared with the scramble group (Fig. 5a). After transfection with Cav-1 shRNA, we treated MDA-MB-231 cells with cholesterol (20 μg/mL in ethanol) at different time points (Fig. 5c).
Fig. 5
The relative protein level of plasma membrane Cav-1. a Plasma membrane proteins were extracted from stably transfected cells. The level of Cav-1 was analyzed by western blotting. The protein expression level was normalized to that of a plasma membrane reference protein, Na+-K+ ATPase α. c Plasma membrane proteins were extracted from MDA-MB-231 cells (Cav-1 shRNA) exposed to free cholesterol for 0 h, 12 h, and 24 h. The levels of ectopic ATP5B and Cav-1 were analyzed by western blotting. b, d, e The statistical results of the western blot analysis (**p < 0.01, n = 3)
×
Anzeige
Relative to that in control cells, the level of ectopic ATP5B was significantly increased following treatment with cholesterol for 12 h and 24 h, while the level of Cav-1 remained unchanged.
Knocking down Cav-1 disrupts the interaction between ectopic ATP5B and Cav-1
To investigate the effect of knocking down Cav-1 on the binding of Cav-1 and ectopic ATP5B, we immunoprecipitated plasma membrane proteins with an antibody against ATP5B, and no isoforms of Cav-1 were detected (Fig. 6). Cells with stable knockdown of Cav-1 were used to evaluate the effects of the interaction between Cav-1 and ectopic ATP5B on the migration and invasion of MDA-MB-231 cells.
Fig. 6
The interaction of ectopic ATP5B and Cav-1 after Cav-1 shRNA transfection. ATP5B was immunoprecipitated from plasma membrane proteins using an anti-ATP5B antibody. The immunoprecipitates were separated by SDS-PAGE for detection of Cav-1
×
Disruption of the binding between ectopic ATP5B and Cav-1 decreases the migration and invasion of MDA-MB-231 cells
To further investigate the role of the binding between ectopic ATP5B and Cav-1 in the migration and invasion of MDA-MB-231 cells, we evaluated the migration/invasion abilities of transfected cells treated or not treated with cholesterol. Regardless of exposure to cholesterol, cells transfected with the Cav-1 shRNA plasmid showed low migration and invasion abilities (Fig. 7). The numbers of migrating/invading cells were increased after scramble vector cells were treated with cholesterol. However, cholesterol loading did not change the migration/invasion abilities of Cav-1 shRNA cells (Fig. 7).
Fig. 7
Cav-1 was involved in the MDA-MB-231 cell migration and invasion induced by ectopic ATP5B. a Transwell migration (n = 3) and invasion (n = 3) assays showed that scramble vector cells exposed to cholesterol had higher migration and invasion potential than untreated cells. Knocking down Cav-1 reduced the cell migration and invasion abilities. Cholesterol loading had no influence on the migration and invasion of Cav-1 shRNA cells. b The statistical results from (A). Data are presented as the mean ± SEM, with n = 3; *p < 0.05, **p < 0.01, ***p < 0.001, two-way ANOVA. Data are representative of three independent experiments
×
Discussion
Metastasis accounts for the vast majority of cancer-related deaths. Migration and invasion of cancer cells is the initial step in tumor metastasis [26]. It is imperative to identify metastasis-associated proteins. In the past decade, the beta subunit of ATPase has been shown to be ectopically expressed on the outer surface of both normal and tumor cells [23, 27‐29] and has been identified as a potential therapeutic target in NSCLC [30] and malignant paragangliomas [31]. Ectopic ATP5B is involved in the metabolism of lipids, activation of endothelial cells [32], development of an acidic tumor microenvironment [33], and proliferation and apoptosis of cancer cells [34]. ATP5B located on the inner membrane of mitochondria is essential for the conversion of ADP to ATP and provides energy for various life processes. Ectopic ATP5B expressed on the plasma membrane of metabolically active tumor cells can also synthesize ATP [28]. In addition, ectopic ATP5B has a tendency to appear on invasive tumor cells. In the preceding work, we confirmed that ATP5B is ectopically expressed on the surface of the highly metastatic human prostate cancer cell line PC-3 M and facilitates the metastasis of PC-3 M cells. The level of ectopic ATP5B in the highly invasive breast cancer cell line MDA-MB-231 is higher than that in the less-invasive cell line MCF-7, suggesting the association of ectopic ATP5B with the migration and invasion of breast cancer cells. We attempted to shed light on the effects of ectopic ATP5B on breast cancer migration and invasion by inducing ectopic expression of ATP5B.
Anzeige
Previously, cholesterol was shown to increase ectopic expression of ATP5B in vascular endothelial cells [25], whereas consumption of cholesterol by β-cyclodextrin decreases ectopic ATP5B expression. Cholesterol replacement caused by endogenous and exogenous ceramides results in a reduction in the level of plasma membrane ATP5B on Schwann cells [35], indicating that cholesterol can regulate ectopic ATP5B expression. To induce ectopic ATP5B expression, MDA-MB-231 cells were exposed to cholesterol for various durations. The level of ectopic ATP5B was significantly increased in cells treated with cholesterol for 12 h but not in cells exposed to cholesterol for 24 h. Induction of increased ectopic expression of ATP5B in breast cancer by cholesterol has a time limitation. Plasma membrane ATP5B assists the endocytosis of HDL as the receptor for apoA. When stimulated by extracellular cholesterol, cells may accelerate cholesterol transport by inducing ectopic expression of ATP5B. However, long-term cholesterol loading triggers regulatory mechanisms in cells, and the level of ectopic ATP5B is subsequently restored. B04, a specific inhibitor of ATP5B, inhibited the migration and invasion of MDA-MB-231 cells regardless of cholesterol exposure. The influence of cholesterol on cell migration and invasion was excluded, which means that an increase in the Cav-1 level alone cannot affect cell migration and invasion. Thus, cholesterol promotes the migration and invasion of MDA-MB-231 breast cancer cells by increasing the level of ectopic ATP5B.
Caveolae are cholesterol-rich microdomains, and cholesterol loading is related to ectopic expression of ATP5B, suggesting that ATP5B is ectopically expressed in caveolae. Researchers confirmed this hypothesis via detergent isolation and proteomic analysis [36, 37]. Caveolae act as molecular hubs, recruiting a large number of signaling molecules. Cav-1 is essential for the formation of caveolae. Lisanti et al. [38] proposed that Cav-1 participated in the integration of multiple signaling pathways. Like ectopic ATP5B, Cav-1 is expressed on the surface of adipocytes, endothelial cells, epithelial cells, and hepatocytes. Therefore, we speculated that Cav-1 may affect the function of ectopic ATP5B by binding to it. The colocalization of ectopic ATP5B and Cav-1 was confirmed by double immunofluorescence staining. The interaction between ectopic ATP5B and Cav-1 was studied by immunoprecipitation. Proteins immunoprecipitated with an anti-ATP5B antibody were separated by SDS-PAGE for detection of Cav-1. Interestingly, only the shorter variant (21 kD) of Cav-1β was detected. Ectopic ATP5B binds to Cav-1β on MDA-MB-231 cells. Two subtypes of Cav-1 have been described. Cav-1β lacks the first 31 N-terminal amino acids of Cav-1α (residues 1–178). Cav-1β was discovered to be present mainly at the edge of migrating cells [39]. This study provides further insight into the two variants.
Cav-1 is related to the processes of proliferation, apoptosis, metastasis, and autophagy in tumor cells and participates in the occurrence and development of tumors [40]. However, the role of Cav-1 in tumors remains controversial [41]. Its tumor suppressive and oncogenic properties have been reported in different tumors. Intriguingly, both contradictory functions can occur within the same tumor type. The effect of Cav-1 on MDA-MB-231 cells was investigated. Cav-1 enhanced migration and invasion of melanoma and breast cancer cells [42, 43]. Cav-1 promotes migration of metastatic breast cancer cells [44]. Interestingly, overexpression of Cav-1 promoted secretion of MMP-3 and MMP-11 (active) proteins, and upregulation of Cav-1 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients [45].
The expression of plasma membrane Cav-1 was significantly decreased after knockdown of Cav-1. In addition, the interaction between ectopic ATP5B and Cav-1 was undetected. The possible reason is that the binding of ATP5B and Cav-1 depends on the levels of the two proteins. MDA-MB-231 cells with stable knockdown of Cav-1 showed decreased migration and invasion potential, which was not reversed by cholesterol, indicating that an increase in the level of ATP5B alone cannot affect cell migration and invasion. Cav-1 was indispensable for the migration- and invasion-promoting function of ectopic ATP5B.
This study provides evidence that Cav-1 is critical for ectopic ATP5B expression. Ectopic ATP5B promotes the migration and invasion of MDA-MB-231 cells by binding to Cav-1. The involved downstream signaling pathways need to be explored further in future studies.
Acknowledgements
The present study was supported by the Natural Science Foundation of Jilin Province, China (Grant No. 20190201091JC).
Declarations
Conflict of interests
The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.
Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.
Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.
Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.
Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.
Update Onkologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
